Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ZYME
ZYME logo

ZYME News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ZYME News

BETA Technologies Reports Disappointing Q4 Results

1d agoBenzinga

Lisata Therapeutics to be Taken Private by Kuva Labs

1d agoBenzinga

Zymeworks (ZYME.US) Insider Plans to Sell $6.13 Million Worth of Common Stock via Form 144

4d agomoomoo

Zymeworks Q4 2025 Earnings Call Highlights

Mar 03 2026seekingalpha

Zymeworks Reports 2025 Financials and $250 Million Financing Agreement

Mar 02 2026NASDAQ.COM

Zymeworks Secures $250 Million Royalty Financing from Royalty Pharma

Mar 02 2026NASDAQ.COM

Zymeworks Reports Expanded Losses in Q4

Mar 02 2026NASDAQ.COM

Zymeworks Secures $250 Million Royalty-Backed Financing

Mar 02 2026Globenewswire

ZYME Events

03/02 09:00
Stock Futures Drop Sharply as Geopolitical Risks Escalate
Stock futures are down meaningfully this morning, priced for risk-off positioning as geopolitical risk escalates sharply. Investors are digesting heightened tensions in the Middle East following coordinated U.S.-Israeli strikes against Iran and subsequent regional retaliation. This has generated widespread volatility and elevated uncertainty across asset classes.Oil prices are surging across global benchmarks on fears of supply disruptions, particularly around the Strait of Hormuz, a critical energy shipping corridor, while safe-haven assets like gold are attracting flows as traders de-risk in response to rising conflict risk.Equity market pressures are broad. European and U.K. stock markets are trading sharply lower, with financials, travel, and cyclicals bearing the brunt of risk aversion, even as defense and energy sectors show relative strength.In pre-market trading, S&P 500 futures fell 1.05%, Nasdaq futures fell 1.32% and Dow futures fell 1.05%.Check out this morning's top movers from around Wall Street, compiled by The Fly.UP AFTER EARNINGS -RadNetup 5%DOWN AFTER EARNINGS -Norwegian Cruise Line (down 7%EchoStar (SATS) down 1%LOWER -uniQuredown 43% after the FDA stated that it cannot agree that data from the Phase I/II studies, compared to an external control, are sufficient to provide the primary evidence of effectiveness required to support a marketing application for AMT-130.UP AFTER STRIKES ON IRAN -AeroVironmentup 10%DHT Holdingsup 9%International Seawaysup 7%ConocoPhillipsup 5%Frontlineup 5%Lockheed Martinup 5%Northrop Grummanup 4%Exxon Mobilup 4%Chevronup 3%DOWN AFTER STRIKES ON IRAN -Delta Air Linesdown 6%American Airlinesdown 6%United Airlinesdown 6%Expediadown 3%Booking Holdingsdown 3%

ZYME Monitor News

Zymeworks Reports Positive Phase 3 Results for Ziihera with Up to $440 Million in Potential Milestones

Jan 15 2026

ZYME.O Surges Past 5-Day SMA, Signaling Bullish Trend

Nov 17 2025

ZYME Earnings Analysis

No Data

No Data

People Also Watch